[go: up one dir, main page]

MX2017009507A - Moléculas de acetogenina con actividad antiplaquetaria y/o antitrombótica y composiciones de las mismas. - Google Patents

Moléculas de acetogenina con actividad antiplaquetaria y/o antitrombótica y composiciones de las mismas.

Info

Publication number
MX2017009507A
MX2017009507A MX2017009507A MX2017009507A MX2017009507A MX 2017009507 A MX2017009507 A MX 2017009507A MX 2017009507 A MX2017009507 A MX 2017009507A MX 2017009507 A MX2017009507 A MX 2017009507A MX 2017009507 A MX2017009507 A MX 2017009507A
Authority
MX
Mexico
Prior art keywords
acetogenin
antiplatelet
molecules
compositions
methods
Prior art date
Application number
MX2017009507A
Other languages
English (en)
Inventor
Graciela Rodriguez Sanchez Dariana
Torre Amione Guillermo
De Jesus Garcia Rivas Gerardo
Hernández Brenes Carmen
Original Assignee
Inst Tecnologico Estudios Superiores Monterrey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Tecnologico Estudios Superiores Monterrey filed Critical Inst Tecnologico Estudios Superiores Monterrey
Publication of MX2017009507A publication Critical patent/MX2017009507A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente divulgación se refiere, según algunas realizaciones, a moléculas de acetogenina que pueden tener actividades antiplaquetaria y/o antitrombótica. En algunas realizaciones, la presente divulgación se refiere a una molécula de acetogenina seleccionada del grupo que comprende: acetogenina 1, acetogenina 2, acetogenina 3, acetogenina 4, acetogenina 5, acetogenina 6, acetogenina 7, acetogenina 8, acetogenina 9, acetogenina 20, acetogenina 11, acetogenina 12, acetogenina 13 y acetogenina 14. La presente divulgación se refiere en algunas realizaciones a una composición farmacéutica que comprende una primera molécula de acetogenina y un vehículo de aporte, en donde la primera molécula de acetogenina se selecciona del grupo que comprende: acetogenina 1, acetogenina 2, acetogenina 3, acetogenina 4, acetogenina 5, acetogenina 6, acetogenina 7, acetogenina 8, acetogenina 9, acetogenina 20, acetogenina 11, acetogenina 12, acetogenina 13 y acetogenina 14.
MX2017009507A 2015-09-23 2015-09-23 Moléculas de acetogenina con actividad antiplaquetaria y/o antitrombótica y composiciones de las mismas. MX2017009507A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2015/002021 WO2017051208A1 (en) 2015-09-23 2015-09-23 Acetogenin molecules having antiplatelet and/or antithrombic activities, and methods and compositions thereof

Publications (1)

Publication Number Publication Date
MX2017009507A true MX2017009507A (es) 2018-07-13

Family

ID=58386058

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017009507A MX2017009507A (es) 2015-09-23 2015-09-23 Moléculas de acetogenina con actividad antiplaquetaria y/o antitrombótica y composiciones de las mismas.

Country Status (4)

Country Link
US (1) US10493057B2 (es)
CA (1) CA2998291C (es)
MX (1) MX2017009507A (es)
WO (1) WO2017051208A1 (es)

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA494110A (en) 1953-06-30 B. Jensen Lloyd Antibiotic from avocado plant
US2550254A (en) 1946-04-05 1951-04-24 Swift & Co Process for extraction of antibiotic material
GB1421129A (en) * 1972-03-03 1976-01-14 Shell Int Research Process for preparing heptadec-16-en-1,2,4-triol derivatives
US5217950A (en) 1988-06-22 1993-06-08 Applied Microbiology, Inc. Nisin compositions for use as enhanced, broad range bactericides
US5458876A (en) 1988-12-21 1995-10-17 Haarman & Reimer Corp. Control of microbial growth with lantibiotic/lysozyme formulations
US5573797A (en) 1989-02-21 1996-11-12 Viskase Corporation Film and method for surface treatment of foodstuffs with antimicrobial compositions
US5573800A (en) 1989-02-21 1996-11-12 Viskase Corporation Antimicrobial composition for surface treatment of foodstuffs
US5573801A (en) 1989-02-21 1996-11-12 Viskase Corporation Surface treatment of foodstuffs with antimicrobial compositions
FR2678632B1 (fr) 1991-07-03 1994-09-02 Pharmascience Lab Procede de preparation de l'insaponifiable d'avocat permettant d'ameliorer sa teneur en l'une de ses fractions dite h.
US5468490A (en) 1993-10-25 1995-11-21 Conkle & Olesten Lipidic furans useful for skin therapeutics
US6057366A (en) * 1994-02-28 2000-05-02 The University Of Queensland Method of treatment of cancer as well as method of inhibition of lactation in mammals
US6133313A (en) 1998-04-27 2000-10-17 The Regents Of The University Of California Insecticidal avocadofurans and triolein
US6326364B1 (en) 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
US6451365B1 (en) 2000-07-14 2002-09-17 Rhodia Inc. Antibacterial composition for control of gram positive bacteria in food applications
FR2798667B1 (fr) 1999-09-22 2001-12-21 Pharmascience Lab Procede d'extraction des composes furaniques et alcools gras polyhydroxyles de l'avocat, composition a base de et utilisation de ces composes en therapeutique, cosmetique et alimentaire
JP2001097828A (ja) 1999-10-01 2001-04-10 Noevir Co Ltd 毛髪用化粧料
US20020037333A1 (en) 2000-08-07 2002-03-28 Yaushi Arimoto Novel hepatic disorder suppressant
JP4693964B2 (ja) 2000-08-07 2011-06-01 カゴメ株式会社 新規摂食抑制剤
ATE306816T1 (de) 2001-04-28 2005-11-15 Miret Lab Kaliumsorbat und lae enthaltende antimikrobielle zusammensetzung
PT1437946E (pt) 2001-10-25 2012-07-25 Miret Lab Utilização de um conservante catiónico em produtos alimentares
DE60315061T2 (de) 2002-06-14 2007-11-22 Ogawa & Co., Ltd. Inhibitor gegen geschmacksbeeinträchtigung und inhibitor gegen die erzeugung eines durch citralbeeinträchtigung entstehenden geruchs
US6994875B2 (en) 2002-07-29 2006-02-07 Laboratoires Expanscience Process for obtaining a furan lipid-rich unsaponifiable material from avocado
FR2893628B1 (fr) 2005-11-18 2008-05-16 Expanscience Laboratoires Sa Procede d'obtention d'une huile d'avocat raffinee riche en triglycerides et huile susceptible d'etre obtenue par un tel procede
JP5085120B2 (ja) 2006-12-21 2012-11-28 日本メナード化粧品株式会社 脳機能改善剤
JP2009164558A (ja) 2007-12-10 2009-07-23 Toyota Central R&D Labs Inc 半導体装置とその製造方法、並びにトレンチゲートの製造方法
BRPI0913835A2 (pt) 2008-07-02 2016-08-09 Miret Lab uso de tensoativos catiônicos como agentes esporicidas
US20100034944A1 (en) * 2008-08-06 2010-02-11 Martha Lubenova Beyazova Use of Avocado Derivatives in Flavor Applications
US20110217251A1 (en) * 2008-09-08 2011-09-08 Shai Meretzki Therapeutic compositions comprising polyhydroxyltate fatty alcohol derivatives and uses thereof
JP2012502020A (ja) 2008-09-08 2012-01-26 ポリオル バイオテク エルティーディー． ポリヒドロキシルテート（ｐｏｌｙｈｙｄｒｏｘｙｌｔａｔｅ）脂肪アルコールおよび誘導体を含む化粧品組成物およびその使用
AU2010309388B2 (en) 2009-10-19 2016-03-10 Laila Nutraceuticals Extracts, fractions and compositions comprising acetogenins and their applications
FR2955782B1 (fr) 2010-01-29 2014-02-14 Expanscience Lab Extraction solide / liquide
JP2013535499A (ja) * 2010-08-09 2013-09-12 インスティテュート テクノロヒコ イ デ エステューディオス スペリオレス デ モンテレイ 生物活性化合物が濃縮されたアボカド抽出物由来の抗菌、抗細菌、または芽胞発芽阻止活性
CL2010000987A1 (es) 2010-09-16 2010-12-24 Instituto De Investig Agropecuarias Extracto alcoholico de cuesco de palta constituido por compuestos del tipo avocadofuranos derivados de la palta tipo persea americana mill; uso del extracto como acaricida contra o. yothersi, t. cinnabarinus y p. citri, e insecticida contra t. vaporariorum.
LT2661266T (lt) * 2011-01-07 2020-12-10 Anji Pharma (Us) Llc Gydimo būdai chemosensorinio receptoriaus ligando pagrindu
FR2984748B1 (fr) * 2011-12-26 2017-02-10 Expanscience Lab Utilisation d'avocats mous entiers pour obtenir une huile d'avocat riche en insaponifiable
US10932484B2 (en) * 2016-10-19 2021-03-02 Instituto Tecnologico Y De Estudios Superiores De Monterrey Inhibitory activity of acetogenins against Listeria monocytogenes

Also Published As

Publication number Publication date
US20180161305A1 (en) 2018-06-14
WO2017051208A1 (en) 2017-03-30
US10493057B2 (en) 2019-12-03
CA2998291C (en) 2022-07-12
CA2998291A1 (en) 2017-03-30

Similar Documents

Publication Publication Date Title
MX2022015755A (es) Profarmacos de hormona paratiroidea (pth).
EP4491184A3 (en) Channel modulators
MX389228B (es) Composiciones para tratar el cabello.
BR112018010585A2 (pt) composições de betume compreendendo lignina
MX2020009223A (es) Anticuerpos anti-fgfr2iiib afucosilados.
WO2017223280A3 (en) COMPOSITIONS AND METHODS FOR RELEASING THERAPEUTIC AGENTS
WO2015073587A3 (en) Synthetic membrane-receiver complexes
SG10201908839QA (en) 2,4-dihydroxy-nicotinamides as apj agonists
EP4545544A3 (en) Modified crispr rna and modified single crispr rna and uses thereof
EP4193993A3 (en) Combinations of cannabinoids and n-acylethanolamines
BR112017028234A2 (pt) composição antimicrobiana
NZ751877A (en) Pertuzumab variants and evaluation thereof
BR112018010381A2 (pt) composições para tratamento de cabelo, condicionadora de cabelo e para alteração da cor do cabelo, sistema para tratamento de cabelo, métodos para tratamento de cabelo e para alteração da cor do cabelo, e, kit de multicompartimentos.
MX2013009252A (es) Composiciones y procesos relacionados con los mismos plaguicidas.
EP4112611A3 (en) Modulators of sestrin-gator2 interaction and uses thereof
PH12017500870A1 (en) Polymer composition comprising basic additive, process and articles comprising said polymer composition
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
EP4378535A3 (en) Antibiotic formulations for lower back pain
GEP201706760B (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
WO2016108927A3 (en) Nitrification inhibitor compositions and methods for preparing the same
WO2017079403A3 (en) Polymeric nanoparticles
MX2018014790A (es) Formulacion combinada de tres compuestos antivirales.
EA032472B9 (ru) Композиция для укладки волос
PH12018000199B1 (en) Compositions containing polymeric carbodiimide, epoxide and polyester-based polymers, their production and use
NZ713440A (en) Nsaid administration and related compositions, methods and systems.